Bitdeer Technologies
BTDR
Bakkt Holdings
BKKT
Riot Platforms
RIOT
TeraWulf
WULF
Canaan
CAN
US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 4.7200
- +0.8300+21.34%
Close Dec 12 16:00 ET
- 4.6200
- -0.1000-2.12%
Post 19:02 ET
42.12MMarket Cap-4.33P/E (TTM)
5.7900High3.8500Low441.10KVolume3.8500Open3.8900Pre Close2.17MTurnover6.52%Turnover RatioLossP/E (Static)8.92MShares6.156852wk High5.65P/B31.92MFloat Cap2.437752wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM49.87%Amplitude0.6700Historical Low4.9250Avg Price1Lot Size
Marker Therapeutics Stock Forum
Sign in to post a comment
$Marker Therapeutics (MRKR.US)$ its been long enough for company to gather data and present. what do you say?
1
$Marker Therapeutics (MRKR.US)$ my little MRKR woke up! wondering do you have news coming 😊
2
$Marker Therapeutics (MRKR.US)$ Reuters· just
Marker Therapeutics Awarded $2 Million Grant From Nih in Support of Phase 1 Study Investigating MT-601 in Car-Relapsed Patients With Non-Hodgkin’s Lymphoma
Marker Therapeutics Awarded $2 Million Grant From Nih in Support of Phase 1 Study Investigating MT-601 in Car-Relapsed Patients With Non-Hodgkin’s Lymphoma
1
$Marker Therapeutics (MRKR.US)$
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma
Marker Therapeutics (Nasdaq: MRKR) has been awarded a $2 million grant from the NIH Small Business Innovation Research program to support the clinical investigation of MT-601 in patients with non-Hodgkin's lymphoma (NHL) who have relapsed following anti-CD19 CAR T cell therapy. The grant will fund the nation...
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma
Marker Therapeutics (Nasdaq: MRKR) has been awarded a $2 million grant from the NIH Small Business Innovation Research program to support the clinical investigation of MT-601 in patients with non-Hodgkin's lymphoma (NHL) who have relapsed following anti-CD19 CAR T cell therapy. The grant will fund the nation...
$Marker Therapeutics (MRKR.US)$ All small biotech companies sell shares on good news, why did Marker previously cancel their sale? Does anyone have any ideas or reason?
$Marker Therapeutics (MRKR.US)$ Marker Therapeutics Says 'MultiTAA-specific T Cell Therapies Demonstrate Clinical Safety and Positive Clinical Data Across Multiple Indications'![]()
8
No comment yet
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Green Dragon 2024 OP : Let’s say 2 weeks